STOCK TITAN

Oramed Pharmaceuticals Inc. (ORMP) Net Income by Year

ORMP

Oramed Pharmaceuticals Inc. reported $64.0M in net income in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Oramed Pharmaceuticals Inc. has filed alongside them.

FY2025 annual
Net Income $64.0M
YoY n/m
5Y CAGR n/m
10Y CAGR n/m
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ORMP Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income$64.0Mn/m-$19.1M-474.6%$5.1Mn/m-$36.6Mn/m-$23.0Mn/m-$11.5Mn/m-$14.4Mn/m-$12.7Mn/m-$10.5Mn/m-$11.0Mn/m-$7.2Mn/m-$5.7M-234.6%$4.2Mn/m-$3.3Mn/m-$1.6M

ORMP Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income$78.2M+488.2%$38.3Mn/mN/A$48.4Mn/m$13.3M+44.2%-$7.6M-597.5%N/A-$19.6Mn/m$9.2Mn/m$1.5Mn/mN/A-$3.2Mn/m

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Oramed Pharmaceuticals Inc. financials

Frequently Asked Questions

What was Oramed Pharmaceuticals Inc.'s net income in fiscal year 2025?

Oramed Pharmaceuticals Inc. reported $64.0M in net income in fiscal year 2025.

How fast is Oramed Pharmaceuticals Inc.'s net income growing?

Oramed Pharmaceuticals Inc. (ORMP) reported a $19.1M net loss in fiscal year 2024 and $64.0M in net income in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

How has Oramed Pharmaceuticals Inc.'s net income changed over the years?

Across the 15 fiscal years this page covers, Oramed Pharmaceuticals Inc. (ORMP) net income went from -$1.6M in fiscal year 2011 to $64.0M in fiscal year 2025.

Oramed Pharmaceuticals Inc. (ORMP) reported $78.2M in net income in Q2 2026. This represents an increase of 488.2% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Oramed Pharmaceuticals Inc. (ORMP) reported on that line in every period on record.